1.26
+0.05(+4.13%)
Currency In USD
| Previous Close | 1.21 |
| Open | 1.21 |
| Day High | 1.37 |
| Day Low | 1.21 |
| 52-Week High | 7.75 |
| 52-Week Low | 0.98 |
| Volume | 90,599 |
| Average Volume | 35,959 |
| Market Cap | 2.54M |
| PE | -0.22 |
| EPS | -5.81 |
| Moving Average 50 Days | 1.17 |
| Moving Average 200 Days | 1.95 |
| Change | 0.05 |
If you invested $1000 in IMAC Holdings, Inc. (BACK) since IPO date, it would be worth $11.41 as of December 26, 2024 at a share price of $1.26. Whereas If you bought $1000 worth of IMAC Holdings, Inc. (BACK) shares 3 years ago, it would be worth $35.59 as of December 26, 2024 at a share price of $1.26.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
GlobeNewswire Inc.
Nov 22, 2024 10:15 PM GMT
FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Marke
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)
GlobeNewswire Inc.
Nov 14, 2024 2:10 PM GMT
FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) to regain
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
GlobeNewswire Inc.
Sep 19, 2024 2:00 PM GMT
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new precision oncology assay for breas